Tucker Kelly
Director of Finance/CFO chez DECIPHERA PHARMACEUTICALS, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Thomas P.
Kelly's current job is as the Chief Financial Officer, Treasurer & Executive VP at Deciphera Pharmaceuticals, Inc. .
Mr. Kelly's former jobs include being a Principal at Canaccord Adams, Inc. from 2003 to 2007, CFO, SVP-Finance & Corporate Development at Critical Therapeutics, Inc. from 2007 to 2008, an Associate at Foley Hoag LLP from 1996 to 1998, Vice President-Life Sciences Investment Banking at Robertson Stephens, Inc. from 1998 to 2002, and Chief Financial Officer at AdvanDx, Inc. from 2012 to 2015.
He also held the position of Chief Financial Officer at deCODE Genetics ehf from 2010 to 2011.
Mr. Kelly's education includes a graduate degree from The University of Chicago Law School and an undergraduate degree from Edmund A.
Walsh School of Foreign Service.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/02/2024 | 80 350 ( 0,10% ) | 1 M $ | 31/03/2024 |
Postes actifs de Tucker Kelly
| Sociétés | Poste | Début |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/02/2015 |
Anciens postes connus de Tucker Kelly
| Sociétés | Poste | Fin |
|---|---|---|
AdvanDx, Inc.
 AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Director of Finance/CFO | 16/03/2015 |
deCODE Genetics ehf
 deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | Director of Finance/CFO | 01/01/2011 |
| Critical Therapeutics, Inc. | Director of Finance/CFO | 04/11/2008 |
Canaccord Adams, Inc.
 Canaccord Adams, Inc. Investment Banks/BrokersFinance Canaccord Adams, Inc. is an independent financial services firm and broker/dealer headquartered in Boston with additional offices in New York City, San Francisco, Evanston, Illinois and Houston, Texas. The firm provides research to help clients make informed investment decisions. Their analysts seek to identify opportunities and expose risk with a focus on emerging and small- to mid-cap growth companies. Canaccord Adams focuses on seven sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. The seven sectors they focus on are: metals and mining, energy, technology, life sciences, real estate and gaming, consumer and industrial growth. Canaccord Adams is a subsidiary of Vancouver-based Canaccord Financial, Inc. They are a member of the NASD and the SIPC. | Corporate Officer/Principal | 01/08/2007 |
| Robertson Stephens, Inc. | Corporate Officer/Principal | 01/07/2002 |
Formation de Tucker Kelly
| The University of Chicago Law School | Graduate Degree |
| Edmund A. Walsh School of Foreign Service | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Canaccord Adams, Inc.
Canaccord Adams, Inc. Investment Banks/BrokersFinance Canaccord Adams, Inc. is an independent financial services firm and broker/dealer headquartered in Boston with additional offices in New York City, San Francisco, Evanston, Illinois and Houston, Texas. The firm provides research to help clients make informed investment decisions. Their analysts seek to identify opportunities and expose risk with a focus on emerging and small- to mid-cap growth companies. Canaccord Adams focuses on seven sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. The seven sectors they focus on are: metals and mining, energy, technology, life sciences, real estate and gaming, consumer and industrial growth. Canaccord Adams is a subsidiary of Vancouver-based Canaccord Financial, Inc. They are a member of the NASD and the SIPC. | Finance |
| Critical Therapeutics, Inc. | Health Technology |
Foley Hoag LLP
 Foley Hoag LLP Miscellaneous Commercial ServicesCommercial Services Foley Hoag LLP provides legal services. It offers international litigation and arbitration services, and counsel in the evolving field of corporate social responsibility. The firm offers practices in industries such as life sciences, health care, technology, energy and renewable, investment management, and professional services. The company was founded in 1943 and is headquartered in Boston, MA. | Commercial Services |
| Robertson Stephens, Inc. | Finance |
AdvanDx, Inc.
AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Health Technology |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | Commercial Services |
